Masimo Announces FDA 510(k) Clearance of Radius VSM
Portfolio Pulse from Benzinga Newsdesk
Masimo Corporation (MASI) has received FDA 510(k) clearance for its Radius VSM, a wearable vital signs monitor. This clearance allows the company to market and sell the device in the United States.
June 05, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Masimo Corporation's Radius VSM receives FDA 510(k) clearance, allowing the company to market and sell the device in the US.
The FDA 510(k) clearance is a significant milestone for Masimo Corporation as it allows the company to market and sell its Radius VSM in the United States. This is likely to have a positive impact on the company's revenues and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100